Add Company
Join Now

iCellate Revenue and Competitors

License our Company Data API

Solna,

Location

N/A

Total Funding

Digital Health

Industry

Estimated Revenue & Valuation

  • iCellate's estimated annual revenue is currently $630k per year.(i)
  • iCellate's estimated revenue per employee is $70,000

Employee Data

  • iCellate has 9 Employees.(i)
  • iCellate grew their employee count by -57% last year.

iCellate's People

NameTitleEmail/Phone
1
Senior ResearcherReveal Email/Phone
2
IT-LeadReveal Email/Phone
3
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$223.4M11165%$65MN/A
#2
$13.6M972%$23.1MN/A
#3
$1.1M13N/AN/AN/A
#4
$87.5M492-4%$206MN/A
#5
$41.9M27218%N/AN/A
#6
$53.4M30522%N/AN/A
#7
$55.8M314-5%$102.6MN/A
#8
$13.6M9713%N/AN/A
#9
$0.2M3N/AN/AN/A
#10
$2.8M29N/AN/AN/A
Add Company

What Is iCellate?

iCellate is a Swedish medtech company furthering cancer research and diagnostics. iCellate pioneers liquid biopsy through detection and analysis of circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) and germline DNA (gDNA).

keywords:N/A

N/A

Total Funding

9

Number of Employees

$630k

Revenue (est)

-57%

Employee Growth %

N/A

Valuation

N/A

Accelerator

iCellate News

2022-04-20 - Emerging Medical Device Technologies Market Size, Outlook And ...

... Abbott Laboratories, Alere Inc., Allergan Plc, Biotronik, Boston Scientific Corp., Harpoon Medical, Heartware, Helioscopie, Hologic, Icellate, Illumina,...

2022-04-20 - Noninvasive Cancer Diagnostics Market By Product Type, Share ...

... iCellate AB, Inivata, IV Diagnostics, and LCM GENECT Srl among others. Market Scenario of Noninvasive Cancer Diagnostics Market.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M12-56%N/A
#2
$2M130%N/A
#3
$1.8M157%N/A
#4
$2.6M18-5%N/A
#5
$2.7M1946%N/A